News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>UBS Adds SWIREPROPERTIES TP to HKD23; Rating Kept Buy
According to a report from UBS, the broker reiterated a Buy rating on SWIREPROPERTIES (01972.HK) and raised its target price from HKD18.1 to HKD23, given that the company benefited...
Reset
Send
The window will close in 5 seconds
<Research>UBS Adds SWIREPROPERTIES TP to HKD23; Rating Kept Buy
Close
Recommend
6
Positive
7
Negative
2
 
SHORT SELL
 
STOCK INFO

According to a report from UBS, the broker reiterated a Buy rating on SWIREPROPERTIES (01972.HK)  -0.020 (-0.100%)    Short selling $2.26M; Ratio 7.506%   and raised its target price from HKD18.1 to HKD23, given that the company benefited from improvements in Hong Kong office leasing and mainland retail fundamentals.

In UBS' estimate, the recent recovery in capital markets will drive a rebound in office leasing inquiries, while the decline in renewal rents will narrow gradually.

Related NewsCiti Ratings, TPs on HK Developers (Table)
Although SWIREPROPERTIES' dividend yield was 6.1% and the net asset value discount rate stood at 57%, investors remained skeptical about the future occupancy rates of the company's mainland retail assets. To UBS, however, the market has not fully accounted for the company's ongoing dividend growth (around 5% per year), the potential asset rotation of Hong Kong residential projects, and the better sentiment in the Hong Kong office leasing market.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-18 12:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.